Ignite Creation Date:
2025-12-24 @ 12:41 PM
Ignite Modification Date:
2026-01-14 @ 7:48 PM
Study NCT ID:
NCT03012061
Status:
COMPLETED
Last Update Posted:
2020-10-28
First Post:
2017-01-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-25
Start Date Type:
ACTUAL
Primary Completion Date:
2018-05-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-05-30
Completion Date Type:
ACTUAL
First Submit Date:
2017-01-04
First Submit QC Date:
None
Study First Post Date:
2017-01-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-05-28
Results First Submit QC Date:
None
Results First Post Date:
2019-06-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-06
Last Update Post Date:
2020-10-28
Last Update Post Date Type:
ACTUAL